CP-060 is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs), particularly those targeting specific disease pathways. Its structural properties make it valuable for creating compounds with potential therapeutic effects, often in the areas of oncology or immunology. Researchers leverage CP-060 to design and optimize drug candidates, ensuring enhanced efficacy and reduced side effects. Additionally, it is employed in preclinical studies to evaluate its pharmacokinetics and pharmacodynamics, aiding in the identification of promising drug leads. Its role in drug discovery underscores its importance in advancing medical treatments and addressing unmet clinical needs.